Last week Barcelona was the place to be with both the colossal Mobile World Congress and the much more targeted Breakthrough Innovations (BI) conference. BI was focused on innovative product development with product leaders from a range of industries, including telecom to consumer products to...
Read More
I'm delighted to announce today that Wellspring has closed a $5M round of growth capital led by MK Capital. We concluded 2013 with our strongest year to date, posting substantial, profitable growth in each of our major sectors: academic markets, corporate innovation / R&D, and health care....
Read More
Its not often you go to Mars. But I spent the last week there and, while its very very hot from a temperature standpoint, the technology and infrastructure are the more impressive aspects.
Read More
Pfizer and the NIH have taken sides on who owns background intellectual property (IP) rights to the blockbuster arthritis drug Xeljanz. Its undisputed that Pfizer invested over $1B in the drug, and its undisputed that Pfizer and NIH had an joint R&D contract, called a CRADA, in place during the...
Read More
R&D has not typically reported on the process they use to generate new innovative ideas, but more often the results. Prior to the advent of the Open Innovation as a business activity R&D had no reason to report on the amount of external collaborations or external partner’s contributions to research...
Read More
We're at the CoDev conference in La Jolla, California. CoDev is co-organized by the PDMA and brings together an exciting array of companies committed to developing their products and services through active partnerships with outside organizations (Co-Development!, Open Innovation, JV's, etc.,).
Read More
Today we launch a new website and with it, a new era for Wellspring Worldwide that has been a decade in the making. The new website marks an exciting time of growth, expansion, and evolution, coinciding with our new corporate headquarters, marketing campaign, and formal launch of new modules and...
Read More